NAK vs. LXRX
NAK (Northern Dynasty Minerals Ltd.) and LXRX (Lexicon Pharmaceuticals, Inc.) are both stocks. NAK operates in Other Industrial Metals & Mining (Basic Materials), while LXRX operates in Biotechnology (Healthcare). Over the past 10 years, NAK returned 21.11%/yr vs -16.88%/yr for LXRX. At a 0.16 correlation, their price movements are largely independent.
Performance
NAK vs. LXRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NAK achieves a 3.55% return, which is significantly lower than LXRX's 86.96% return. Over the past 10 years, NAK has outperformed LXRX with an annualized return of 21.11%, while LXRX has yielded a comparatively lower -16.88% annualized return.
NAK
- 1D
- -2.86%
- 1M
- -1.45%
- YTD
- 3.55%
- 6M
- -12.07%
- 1Y
- 53.38%
- 3Y*
- 110.57%
- 5Y*
- 32.37%
- 10Y*
- 21.11%
LXRX
- 1D
- 6.97%
- 1M
- -0.46%
- YTD
- 86.96%
- 6M
- 76.23%
- 1Y
- 186.67%
- 3Y*
- -3.20%
- 5Y*
- -14.70%
- 10Y*
- -16.88%
NAK vs. LXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NAK Northern Dynasty Minerals Ltd. | 3.55% | 238.78% | 79.86% | 46.42% | -32.31% | 1.30% | -25.12% | -24.46% | -67.84% | -14.49% |
LXRX Lexicon Pharmaceuticals, Inc. | 86.96% | 55.72% | -51.73% | -19.90% | -51.52% | 15.20% | -17.59% | -37.50% | -32.79% | -28.56% |
Correlation
The correlation between NAK and LXRX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Oct 9, 2003 | 0.16 |
Fundamentals
NAK:
$1.12B
LXRX:
$860.52M
NAK:
-CA$0.19
LXRX:
-$0.07
NAK:
89.69
LXRX:
4.24
NAK:
CA$0.00
LXRX:
$69.64M
NAK:
-CA$85.85K
LXRX:
$69.00M
NAK:
-CA$99.80M
LXRX:
-$20.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NAK vs. LXRX — Risk / Return Rank
NAK
LXRX
NAK vs. LXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Northern Dynasty Minerals Ltd. (NAK) and Lexicon Pharmaceuticals, Inc. (LXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NAK | LXRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.75 | ||
| Sortino ratioReturn per unit of downside risk | -1.44 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.34 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.79 | 5.51 | -4.72 |
| Martin ratioReturn relative to average drawdown | 1.35 | 11.69 | -10.35 |
Loading charts...
Drawdowns
NAK vs. LXRX - Drawdown Comparison
The maximum NAK drawdown since its inception was -99.01%, roughly equal to the maximum LXRX drawdown of -99.91%. Use the drawdown chart below to compare losses from any high point for NAK and LXRX.
Loading charts...
Drawdown Indicators
| NAK | LXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.01% | -99.91% | +0.90% |
Max Drawdown (1Y)Largest decline over 1 year | -67.68% | -34.09% | -33.59% |
Max Drawdown (3Y)Largest decline over 3 years | -67.68% | -91.83% | +24.15% |
Max Drawdown (5Y)Largest decline over 5 years | -67.68% | -95.25% | +27.57% |
Max Drawdown (10Y)Largest decline over 10 years | -93.79% | -98.48% | +4.69% |
Current DrawdownCurrent decline from peak | -90.32% | -99.35% | +9.03% |
Average DrawdownAverage peak-to-trough decline | -73.94% | -93.27% | +19.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.73% | 16.03% | +23.70% |
Volatility
NAK vs. LXRX - Volatility Comparison
Northern Dynasty Minerals Ltd. (NAK) has a higher volatility of 25.20% compared to Lexicon Pharmaceuticals, Inc. (LXRX) at 16.67%. This indicates that NAK's price experiences larger fluctuations and is considered to be riskier than LXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NAK | LXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.20% | 16.67% | +8.53% |
Volatility (6M)Calculated over the trailing 6-month period | 77.34% | 58.10% | +19.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 115.41% | 84.95% | +30.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.94% | 98.30% | -14.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.98% | 97.26% | +0.72% |
Dividends
NAK vs. LXRX - Dividend Comparison
Neither NAK nor LXRX has paid dividends to shareholders.
Financials
NAK vs. LXRX - Financials Comparison
This section allows you to compare key financial metrics between Northern Dynasty Minerals Ltd. and Lexicon Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NAK and LXRX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NAK has higher volatility (25.20%) compared to LXRX (16.67%). In terms of maximum drawdown, NAK dropped -99.01% vs LXRX's -99.91%.
LXRX currently has the higher Sharpe Ratio (2.22 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NAK and LXRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer